✦ LIBER ✦

Safety of minimal immunosuppression in liver transplantation for hepatoblastoma

✍ Scribed by Matthew Y. Suh; Kathleen Wang; Jordan R. Gutweiler; Meghna V. Misra; Laura E. Krawczuk; Roger L. Jenkins; Craig W. Lillehei; Maureen M. Jonas; Heung Bae Kim

Book ID: 116687138
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 149 KB
Volume: 43
Category: Article
ISSN: 0022-3468
DOI: 10.1016/j.jpedsurg.2008.02.045

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Towards minimizing immunosuppression in

Towards minimizing immunosuppression in pediatric liver transplant recipients

✍ Yumirle P. Turmelle; Michelle L. Nadler; Christopher D. Anderson; Maria B. Doyle 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Immunosuppression minimization vs. compl

Immunosuppression minimization vs. complete drug withdrawal in liver transplantation

✍ Londoño, Maria-Carlota; Rimola, Antoni; O’Grady, John; Sanchez-Fueyo, Alberto 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 710 KB

Liver transplantation for the management

Liver transplantation for the management of hepatoblastoma

✍ U Cillo; F.A Ciarleglio; M Bassanello; A Brolese; A Vitale; P Boccagni; G Zanus; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Liver transplantation for hepatoblastoma

Liver transplantation for hepatoblastoma in the pediatric population

✍ E.P Molmenti; D Nagata; J Roden; R Squires; H Molmenti; D Casey; C Fasola; G Tom 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Strategies for minimizing immunosuppress

Strategies for minimizing immunosuppression in kidney transplantation

✍ Allan D. Kirk; Roslyn B. Mannon; S. John Swanson; Douglas A. Hale 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 117 KB

Future prospects in immunosuppression fo

Future prospects in immunosuppression for liver transplantation

✍ John J. Fung; Jessica E. Bollinger; Charles Miller; Bijan Eghtesad 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Key Points 1. Our increasing understanding of signaling pathways and cellular interactions in transplant immunobiology and the availability of novel immunosuppressive agents have facilitated targeted strategies. 2. The driving forces behind the development of new immunosuppressive regimens are t